RxDoctor Payments Data

Corey Haber, DO

Family Medicine · Auburn Hills, MINPI 1598856841

Payments from drug & device makers

$727in general payments, 2019–2025

Across 41 payments — averaging $17.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$369
  • AstraZeneca$163
  • Pfizer$72
  • Novo Nordisk$35
  • Dexcom, Inc.$26
  • Amgen$17
  • plus $45 from 3 others

What the payments were for

  • Food & beverage$727100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$727 in reported general payments places this provider in the 65th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$278,754
Medicare patients
319
Services billed
6,931

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide171$206,521
FarxigaDapagliflozin Propanediol241$199,133
JardianceEmpagliflozin181$182,942
JanuviaSitagliptin Phosphate116$139,256
EliquisApixaban130$137,870
TrulicityDulaglutide55$80,836
Trelegy ElliptaFluticasone/Umeclidin/Vilanter86$68,417
MounjaroTirzepatide43$48,859
XareltoRivaroxaban37$34,949
PaxlovidNirmatrelvir/Ritonavir35$20,458
RybelsusSemaglutide14$18,240
LinzessLinaclotide12$16,710
EntrestoSacubitril/Valsartan17$15,939
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr20$14,026
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate25$13,159

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere, Lokelma, Brilinta$163$232,317294 claims
Novo NordiskOzempic, Rybelsus$35$224,761185 claims
PfizerEliquis, Paxlovid$72$158,328165 claims
Lilly USA, LLCTrulicity, Mounjaro$17$129,69698 claims
GSKTrelegy Ellipta, Anoro Ellipta, Shingrix, Breo Ellipta, Arnuity Ellipta$369$106,020185 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Auburn Hills

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →